GT BIOPHARMA, INC. |
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.55 EUR | -86.52% |
|
-96.67% | -99.80% |
| 27/06 | GT Biopharma Says FDA Clears Investigational New Drug Application for Cancer Drug GTB-3650 | MT |
| 27/06 | GT Biopharma Shares Rise on FDA Clearance for Cancer-Drug Study | DJ |
Quotes 5-day view
Real-time Euronext Paris| 11/07/2024 | 12/07/2024 | 15/07/2024 | 16/07/2024 | |
|---|---|---|---|---|
| Last | 16.5 € | 16.5 € | 16.5 € | 16.5 € |
| Change | -.--% | -.--% | -.--% | -.--% |
Performance
| 1 day | -86.52% | ||
| 1 week | -96.67% | ||
| Current month | -96.67% | ||
| 1 month | -96.67% | ||
| 3 months | -94.12% | ||
| 6 months | -99.80% | ||
| Current year | -99.80% | ||
| 1 year | -99.80% | ||
| 3 years | -99.80% | ||
| 5 years | -99.90% | ||
| 10 years | -100.00% |
Volumes
marketsCapital turnover ratio
0.00
Float rotation
0.00
Basic data
Capitalization (EUR)
6 081 755
Capitalization (USD)
6 081 755
Net sales ()
0
Free-Float
89.34 %
Free-Float capitalization (EUR)
5 676 180
Free-Float capitalization (USD)
5 676 180
Highs and lows
1 week
9.35
16.50
1 month
9.3516.50
Current year
9.35280.50
1 year
9.35280.50
3 years
9.35280.50
5 years
9.35280.50
10 years
9.351 000 000.00
Indicators
Moving average 5 days
4.62
Moving average 100 days
26.52
Price spread / (MMA5)
+739.71%
Price spread / (MMA100)
+4,721.45%
RSI 9 days
0.00
RSI 14 days
0.00
Sector Comparison - Other Pharmaceuticals
| Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
|---|---|---|---|---|---|---|
| -86.52% | -96.67% | -99.80% | -99.80% | 6.08M | ||
| -0.93% | +0.98% | +61.53% | +109.50% | 848B | ||
| -3.96% | -2.89% | +35.80% | +76.87% | 627B | ||
| +1.19% | +2.69% | -3.66% | -5.54% | 363B | ||
| -2.09% | -0.48% | +15.06% | +16.86% | 318B | ||
| +0.70% | +0.68% | +9.18% | +24.40% | 299B | ||
| +5.27% | +5.85% | +5.89% | -4.54% | 234B | ||
| -1.29% | +0.13% | +15.98% | +15.91% | 225B | ||
| +0.91% | +5.45% | +15.67% | +46.48% | 179B | ||
| +1.37% | +6.42% | +2.47% | -18.78% | 167B | ||
| -0.11% | -1.86% | +2.28% | -2.50% | 125B | ||
| +1.17% | +5.73% | -11.57% | -7.19% | 89.25B | ||
| +2.62% | +0.83% | -19.70% | -33.48% | 83.52B | ||
| -0.27% | -0.49% | +3.27% | +13.58% | 79.3B | ||
| +1.00% | +3.34% | +56.84% | +55.60% | 72.39B | ||
| -0.08% | -5.25% | +13.42% | +55.04% | 62.91B | ||
| Average | -5.13% | +1.90% | +6.42% | +15.15% | ||
| Weighted average by Cap. | -0.31% | +1.70% | +24.35% | +43.53% |
Historical data
| Date | Opening | High | Low | End-of-day | Volume |
|---|
Monthly variations
Annual change
| 2024 | -94.12% | ||
| 2023 | -.--% | ||
| 2020 | -46.60% | ||
| 2018 | -77.11% | ||
| 2017 | -90.63% | ||
| 2016 | -93.94% | ||
| 2015 | +5.42% | ||
| 2014 | -.--% | ||
| 2013 | -.--% | ||
| 2012 | -50.00% | ||
| 2011 | -81.82% | ||
| 2010 | -31.25% | ||
| 2009 | +220.00% | ||
| 2008 | -44.44% | ||
| 2007 | -52.63% | ||
| 2006 | -20.83% | ||
| 2005 | -29.41% | ||
| 2004 | -38.18% | ||
| 2003 | +323.08% | ||
| 2002 | -18.75% | ||
| 2001 | -75.00% | ||
| 2000 | -65.41% | ||
| 1999 | -1.74% | ||
| 1998 | -22.38% | ||
| 1997 | -49.53% |
- Stock Market
- Equities
- GTBP Stock
- GTBP Stock
- Quotes GT Biopharma, Inc.
